|
|
| | DCLK1-IN-1 Basic information |
| Product Name: | DCLK1-IN-1 | | Synonyms: | DCLK1-IN-1;5,11-Dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-5-(2,2,2-trifluoroethyl)-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one;6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-5-(2,2,2-trifluoroethyl)-;DCLK1 IN 1,signaling,PDAC,KRAS,cancer,low,ERK,Inhibitor,selective,DCLK1IN1,inhibit,DCLK-1-IN-1,toxicity | | CAS: | 2222635-15-4 | | MF: | C26H28F3N7O2 | | MW: | 527.54 | | EINECS: | | | Product Categories: | | | Mol File: | 2222635-15-4.mol |  |
| | DCLK1-IN-1 Chemical Properties |
| Boiling point | 692.4±65.0 °C(Predicted) | | density | 1.331±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: 35.71 mg/mL (67.69 mM) | | pka | 7.75±0.42(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | DCLK1-IN-1 Usage And Synthesis |
| | DCLK1-IN-1 Preparation Products And Raw materials |
|